Skip to main content
. Author manuscript; available in PMC: 2020 May 9.
Published in final edited form as: Eur Cell Mater. 2019 Nov 22;38:246–263. doi: 10.22203/eCM.v038a17

Table 2. DEX studies using explants from human or animal cartilage in models of arthritis.

Summary of DEX concentration, duration of culture, inflammatory cytokines used to model arthritic conditions and observed effect on measurements associated with arthritis progression. APC: activated protein C. + indicates a rescue of arthritis-induced effects, +/= rescue of only some effects and +/− rescue of some effects and worsening of others. Wang et al. (2014) Dexamethasone treatment alters the response of human cartilage explants to inflammatory cytokines and mechanical injury as revealed by discovery proteomics. Osteoarthritis Cartilage 25: S381–S382.

Authors Year Tissue type Cytokine treatment DEX dose Duration Observed effect
Li et al. 2015 Human ng/mL IL-1α nM d +
Bovine ng/mL IL-1α nM d +/=
Wang et al. 2014 Human ng/mL TNFα + 50 ng/mL IL-6 nM d +
Lu et al. 2011 Human ng/mL TNFα ± 50 ng/mL IL-6 nM d +
Bovine ng/mL TNFα ± 50 ng/mL IL-6 nM d +
Busschers et al. 2010 Equine ng/mL IL-1β nM-1 μM h +/=
Garvican et al. 2010 Equine ng/mL IL-1 + 10 μg/mL APC 1–100 μM d +/−
Saito et al. 1999 Rabbit ng/mL IL-1α + 100 μg/mL plasminogen 0.1–100 nM d +